Georgia — Country Health & Migration Assessment 2026
PHIG Country Health & Migration Assessment Tool v6.0 · 19-indicator instrument · Independent researcher assessment
Assessment Year: 2026Data: 2023–2024Assessor: Prof. G. Pkhakadze · ORCID 0000-0001-7609-4515
⚠ Independent PHIG researcher assessment — not a government self-assessment · Not an official WHO position
Georgia sits at one of the most consequential migration crossroads in the WHO European Region. Over the past decade the country has simultaneously experienced mass outward emigration (861,000 citizens abroad — 23% of the population), a 30-year IDP crisis (288,000 internally displaced), and surging inward transit migration. In 2023 alone, net emigration reached −71,584 — the highest on record. Georgia’s UHCP (2013) reduced OOP from 82% to ~30% (2022) within a decade — a genuine reform achievement — yet the system generates zero migration-disaggregated health data across every national database. EU accession candidacy (2023) creates the first binding institutional deadline for change.
- ~861,000 Georgian citizens abroad (23% of population; UN 2020)
- Net emigration 2023: −71,584 (record, GeoStat); cumulative −265K (2014–23)
- 70% of emigrants under 30; 43% of emigrant children under 15
- 288,000 IDPs — largest IDP:population ratio in Europe (~40% in Tbilisi)
- ~1,500 UNHCR-recognised refugees; transit country for Central/South Asian migrants to EU
- Remittances: ~13% GDP (falling); Russia share now 16% (was 54% in 2013)
- UHCP (Universal Health Care Programme) since 2013 — OOP ~30% (2022) (from 82%)
- Health spend/capita PPP: $1,413 vs region avg $3,841 — significant gap
- Catastrophic health spending: 17% of households (2018)
- Physicians: 561/100K (above EUR avg 387) — but 38.9% aged 55+
- Nurses: 588/100K — nurse:MD ratio 1.05:1, lowest in WHO European Region
- TB incidence: 59/100K — above EUR average; makes cross-border screening critical
- Male smoking 54.6%: highest in EUR · COVID-19 excess mortality: 434/100K (region avg 144)
- EU accession candidate 2023 — creates binding health equity obligations
| Life expectancy | 73.7 yrs (region avg 78.2) |
| UHCP coverage | 93.7% (2023) |
| OOP % health spend | ~30% (2022) (2021) — was 82% (2011) |
| Public spend % GDP | 3.1% (2022); COVID peak 4.5% |
| Health spend/capita PPP | $1,413 vs region $3,841 |
| Catastrophic health spending | 17% of households (2018) |
| Under-5 mortality | 9.8/1,000 live births |
| Maternal mortality | 28/100,000 live births |
| Hospital beds | 2.3/1,000 (~80% private) |
| COVID excess mortality 2021 | 434/100K (region avg 144/100K) |
| Causes of Death | |
|---|---|
| Cardiovascular disease | 22,108 deaths (47%) |
| Respiratory diseases | 13,773 (29%) |
| Cancers | 7,389 (16%) |
| Top DALYs Lost (/100,000) | |
| COVID-19 | 7,413 |
| Stroke | 5,110 |
| Ischaemic heart disease | 4,160 |
| Tobacco-attributable | 3,400 |
| Depression | 2,800 |
16,000
15,000
~10,000 fastest growing
$19.4M
$19.0M
Trust Deficit: HIGH
No hospital discharge, cancer registry, TB/HIV notification, vaccination record, vital statistics certificate, or primary care EHR in Georgia carries a migration status variable. This means 861,000 citizens abroad, 288,000 IDPs, and the −71,584 persons who emigrated in 2023 are entirely invisible to the HIS. WHO Tool 14 not initiated. SDG 17.18 compliance: 0%. The national EHR in development (2024–26) is the last structural window before architecture locks. EU accession (candidate status 2023) creates binding European Health Data Space obligations — the most powerful institutional lever in this assessment.
Georgia has 561 physicians/100K (above EUR avg 387) but only 588 nurses/100K (EUR avg 784). Nurse:MD ratio 1.05:1 vs EUR norm 2.5:1 — the lowest recorded in the region. 38.9% of physicians aged 55+. Record emigration 2023 depletes nursing further. No WHO Competency Standards in any Georgian medical school. No cultural humility, structural competency, or migration-sensitive intake protocol exists. Exception: PHIG/DTMU delivered WHO CS training Riga Sept 2024 — Prof. Pkhakadze facilitated (cited WHO/Europe website). Institutional capacity exists; curriculum embedding is pending.
No national migrant or refugee health strategy exists despite WHO GAP 2019–2030 commitment. The UHCP (2013) mentions refugees only incidentally. No interministerial coordination mechanism. No anti-racism policy in the health sector. 288,000 IDPs displaced for 30+ years without a formal health equity strategy. EU accession is the strongest structural lever: the candidate process requires national health equity strategies with European Commission benchmarking.
Georgia does not require healthcare providers to report undocumented migrants to immigration authorities. Emergency care is accessible without identity documents. Health records not shared with immigration enforcement. This structurally low hostile environment must be actively protected as EU accession could inadvertently introduce new administrative barriers. PHIG recommendation: explicitly protect this provision in EU accession health chapter negotiations.
| Obligation | Ratified? | Operationalised? |
|---|---|---|
| 1951 Refugee Convention | Yes | Partial — UHCP gap |
| ICESCR Art.12 (all persons) | Yes | No — emergency only |
| GCM Objective 15 | Endorsed | No domestic instrument |
| WHO GAP national plan | Committed | Not produced (6+ years) |
G4: No IHR-aligned mass migration health response plan. 288,000 IDPs managed 30+ years without one. Georgia borders Russia (conflict zone), is an EU transit corridor — absence is operationally critical.
G5: Anti-discrimination law (2014) exists. No health-sector anti-racism strategy — racism not named explicitly; no targets; no accountability (O’Neill-Lancet 2023 framework). IDP 30-year structural exclusion never formally addressed.
| Population category | Population (0–4) | Services (0–4) | Cost protection (0–4) | Cube /12 |
|---|---|---|---|---|
| Recognised refugees | 3 | 2 | 2 | 7/12 |
| Asylum seekers | 2 | 2 | 1 | 5/12 |
| Labour migrants (regular) | 2 | 1 | 1 | 4/12 |
| Undocumented migrants | 1 | 1 | 0 | 2/12 |
| IDPs | 3 | 2 | 2 | 7/12 |
F3: Georgia is among 66 of 79 ILO non-reporting countries on OHS data by migration status. Construction, agriculture, domestic work sectors — significant migrant labour presence — invisible to OHS surveillance. Score: 1/4.
| WHO CS Domain | Pre-service | CPD | Coverage |
|---|---|---|---|
| D1: Migration & health context | None | None specific | <5% |
| D2: Ethics & human rights | Partial (general ethics) | None migration-specific | <5% |
| D3: Clinical & public health | TB/HIV vertical only | Vertical programmes only | 10–20% |
| D4: Cross-cultural communication | None | None | <5% |
| D5: Leadership & advocacy | None | None | <5% |
| Service type | Recognised refugees (A/Ac/Ac/Q/T) | Undocumented migrants (A/Ac/Ac/Q/T) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Emergency care | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Primary / PHC | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Mental health | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MCH / Obstetric | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| TB / Infectious | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 |
S3: No national protocol based on CCIRH 20-condition list. TB screened (vertical NTP). HIV screened (vertical). Not screened: Strongyloides, Schistosomiasis, latent TB/IGRA, PTSD/Depression (validated tools), Vitamin D, lead toxicity in children. Georgia TB 59/100K — makes screening of mobile populations a public health imperative. Score: 1/4.
- Hospital discharge database: no migration status variable
- Cancer registry: no migration status variable
- Vital statistics: nationality only — not legal status or IDP status
- National vaccination registry (EIMV): excludes undocumented by design (requires PIK)
- TB/HIV surveillance: nationality only — not migration status or displacement history
- Primary care EHR (in development 2024–26): no migration field planned in current specification
WHO Tool 14: not initiated. SDG 17.18 compliance: 0%. The EHR development window is the last structural opportunity before architecture locks for a decade. EU accession creates binding European Health Data Space obligations as the primary institutional lever.
D3 Participatory research: No documented example of participatory research with migrants/IDPs as co-researchers. Studied as subjects — never design researchers. MacFarlane et al. Lancet 2024 (participatory research as WHO/Europe policy) not operationalised in Georgia. Score: 1/4.
| Service / Population | Entitlement (0–4) | Utilisation est. | Trust Deficit | Primary mechanism |
|---|---|---|---|---|
| Primary care — Refugees | 2 | ~1 | Moderate (1) | Language; navigation; pharmaceutical OOP |
| Primary care — Undocumented | 1 | ~0 | High (1–2) | Fear; cost; no ID; no interpreter |
| Primary care — IDPs | 3 | ~2 | Moderate (1) | Geographic remoteness; pharmaceutical OOP; 30-year disillusionment |
| Mental health — All mobile | 1 | ~0 | High (1–2) | Stigma; language; no trauma-informed pathway |
Overall Trust Deficit: HIGH. ~30% (2022) OOP is the primary structural mechanism — even covered populations face pharmaceutical costs suppressing utilisation. Cannot be reduced without (a) migration status in HIS and (b) reduced pharmaceutical OOP.
CC3 Digital (1/4): National e-health portal and EHR require Georgian personal ID (PIK) — undocumented excluded by design. No language-adapted digital tools. EU Digital Health Single Market framework will create accessibility obligations through accession.
CC4 Cosmopolitan UHC (1.25/4): Supranational governance 2/4 (EU future pathway) · Cross-border care continuity 1/4 (no bilateral agreement) · Harmonised legal frameworks 2/4 (not operationalised) · Long-term investment 0/4 (no cost-of-exclusion analysis published).
| # | Key Indicator | Georgia 2026 Finding | Score |
|---|---|---|---|
| 1 | Trust Deficit | HIGH — ~30% (2022) OOP + pharmaceutical exclusion + IDP disillusionment + no utilisation data | HIGH |
| 2 | Cost of exclusion estimate | Not published — UHCP 12 years old; IDP crisis 30+ years | Absent |
| 3 | Hostile environment | LOW ✓ — no reporting; no ID for emergency; no immigration data sharing | Low |
| 4 | Duty bearer compliance | Ratifies but does not operationalise — pattern across all instruments | 1.3/4 |
| 5 | UHC Coverage Cube | Refugees 7/12; undocumented 2/12 — pharmaceutical gap universal | Partial |
| 6 | Political climate | 2/4 — EU aspiration vs. democratic backsliding; IDP solidarity without strategy | 2/4 |
| 7 | Brain drain rate | HIGH — nurse:MD 1.05:1 (lowest EUR); 38.9% MDs 55+; emigration unmeasured | 1/4 |
| 8 | Cultural humility | Absent — not in any Georgian medical or nursing training programme | 0/4 |
| 9 | Structural competency | Absent — biomedical model dominates; no social determinants clinical training | 0/4 |
| 10 | Expanded social history | Absent — no migration-sensitive intake protocol in any clinical setting | 0/4 |
| 11 | ILO OHS data | Absent — among 66/79 non-reporting ILO countries | 0/4 |
| 12 | Anti-racism policy | Anti-discrimination law only (2014) — no health-sector anti-racism instrument | 1/4 |
| 13 | Supranational financing | EU accession creates future pathway — no operational mechanism currently | 2/4 |
| 14 | Migration health in higher ed. | Absent — not in DTMU, TSU, AIETI, or AMTU curricula; MPH redesign pending | 0/4 |
| 15 | Participatory research | Absent — migrants and IDPs studied as subjects; not as co-researchers | 0/4 |
| # | Recommendation | Action required | Lead | Target | MHSS lever |
|---|---|---|---|---|---|
| R1 | Embed migration status in the national EHR — implement WHO Toolkit Module 4, Tool 14 before EHR architecture is finalised | Add legal status, country of origin, IDP flag, and language as core variables in the EHR specification currently in development. Frame as EU Health Data Space compliance. | MoHLSA / NCDC / EU technical advisory | Q2 2026 — before EHR specification locks | HIS B5 (1.0→2) |
| R2 | Publish a National Migrant Health Action Plan implementing WHO GAP 2019–2030 national plan requirement and GCM Objective 15 | Draft and endorse a ministerial-level action plan. Frame as EU Chapter 28 (Consumer and Health Protection) deliverable. Establish an interministerial focal point within MoHLSA. | MoHLSA / WHO Country Office Tbilisi / PHIG | End 2026 | Governance B1 (1.8→3) |
| R3 | National nursing retention and return strategy — address the 1.05:1 nurse:MD ratio before the physician retirement wave | Develop financial incentives for rural nursing; diaspora re-registration pathway; bilateral mobility agreements with Germany, UK, USA. Aligned with WHO Nursing and Midwifery Strategic Directions 2021–2025. | MoHLSA / Ministry of Finance / EU4Health window | 2026 | Workforce B3 (1.4→2) |
| R4 | Extend UHCP to include outpatient NCD medicines for antihypertensives, diabetes, and respiratory conditions — the WHO-PEN essential package | Phase pharmaceutical coverage extension into the UHCP 2025 revision. Model on WHO-PEN tier-1 priority list. Identify EU4Health or World Bank IDA window for co-financing. Target: cardiovascular NCD medicines first. | MoHLSA / MoFinance / World Bank | 2026–2027 | Financing B2 (2.3→3) |
| R5 | Integrate WHO Competency Standards for Refugee and Migrant Health into pre-service training at DTMU, TSU, AIETI, and AMTU | PHIG/DTMU School of Public Health to lead curriculum integration in MPH redesign. Scale 2024 Riga training model (WHO/IOM/EU framework) to national pre-service coverage. Include cultural humility (Tervalon & Murray-García), structural competency (Metzl & Hansen), and expanded social history modules. | PHIG / DTMU School of Public Health / WHO/Europe | 2026–2027 academic year | Workforce B3 (1.4→2.5) |
| R6 | Enact comprehensive tobacco control legislation meeting WHO FCTC minimum standards — smoke-free law, tobacco taxation, mass media campaigns | Georgia is an FCTC signatory; comprehensive legislation has not been enacted. Male smoking 54.6% (highest in EUR) is the leading modifiable behavioural risk driver for CVD mortality. WHO Best Buys for NCD prevention are available within existing legal framework. No technical barrier exists — this is a political prioritisation decision. | Parliament of Georgia / MoHLSA / WHO Country Office | 2026–2027 | Disease burden (NCD cycle) |
New primary source (December 2024): Richardson E, Tvaliashvili M, Gviniadze K, Roubal T. Health systems in action 2024: Georgia. Copenhagen: WHO Regional Office for Europe / European Observatory on Health Systems and Policies; 4 December 2024. ISBN 9789289059770. CC BY-NC-SA 3.0 IGO. — The most recent WHO authoritative assessment of the Georgian health system.